There are 2949 resources available
Welcome and introduction
Presenter: Tanja Cufer
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
Treatments After Progression in the First-Line of Non-Mutated NSCLC Adenocarcinoma
Presenter: Silvia Novello
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
Uncommon EGFR mutations
Presenter: Xiuning Le
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
The Future of NSCLC
Presenter: Melissa Johnson
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
Key insights and closing remarks
Presenter: Tanja Cufer
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
Challenges in the treatment of prostate cancer
Presenter: Daniel George
Session: Pfizer Oncology - Building a new paradigm in prostate cancer
Resources:
Webcast
Maximizing outcome with NHTs
Presenter: Arnulf Stenzl
Session: Pfizer Oncology - Building a new paradigm in prostate cancer
Resources:
Webcast
Expanding the potential of PARP inhibitors
Presenter: Joaquin Mateo
Session: Pfizer Oncology - Building a new paradigm in prostate cancer
Resources:
Webcast
Summary
Presenter: Daniel George
Session: Pfizer Oncology - Building a new paradigm in prostate cancer
Resources:
Webcast
Optimising care for individual patients with metastatic hormone sensitive prostate cancer
Presenter: Nicolas Mottet
Session: Janssen - Advanced prostate cancer: How do we move forward in patient management?
Resources:
Webcast